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Introduction
Poultry production in Argentina has grown during last years 
because of an increase in consumption of poultry and poultry products. 
Chicken consumption increased from 20 kg/person/year in 2000 to 44 
kg for the last years.1 Due to the increase in demand of animal protein 
in population’s diet, important investments were implemented in the 
poultry sector by means of technological improvements, genetics, 
animal welfare, health and nutrition, which in turn contributed to 
the development and intensification of this activity. For this reason, 
activities related to poultry production are betting to include new 
technologies, extreme quality and sanitary controls. An example of this 
is the control of residues and contaminants that exceed those values 
allowed in the meat made by national inspection bodies in order to 
take care on behalf of consumer health, to punish the noncompliance 
of current regulations and to maintain a free market to export products 
produced in Argentina.
Tetracyclines are the most commonly used antimicrobials in 
food–producing animals. They are broad spectrum antimicrobials 
widely used in poultry farms because of their great activity against 
Gram–positive and Gram–negative bacteria, and intracellular 
microorganisms. Doxycycline (DOX) is a semi–synthetic 
bacteriostatic tetracycline which tends to be more active against the 
spectrum of microorganisms, including Rickettsiae, Chlamydiae, 
Mycoplasmas and some Protozoa.2,3 Therefore, DOX is used for the 
treatment of respiratory, urinary and gastrointestinal tract diseases.4
Pharmacokinetics properties of DOX are superior than older 
tetracycline; in terms of higher lipid solubility, complete absorption, 
better tissue distribution, longer elimination half–life and lower affinity 
for calcium.5,6 It has good bioavailability after oral administration, and 
it is widely distributed in the body. Plasma protein binding is greater 
than other tetracyclines and all these characteristics contribute to 
maintain plasma concentration for long periods requiring less frequent 
doses than other members of the tetracycline family.7,8 The route of 
drug administration plays an important role in the effectiveness of the 
treatment, as well as in the distribution of antibiotics to tissues.9
The prudent use of antimicrobials in poultry industry results in 
many benefits. Antibiotics are used in chickens to enhance growth, 
feed efficiency and reduce diseases. Additionally, prophylactic 
treatment is common during periods of stress. Although there are 
few pharmacokinetic studies in chickens, it is frequently used for the 
treatment of colibacillosis, salmonellosis, staphylococcal infections, 
avian mycoplasmosis and chlamydiasis.10
Some antimicrobials may leave residues in several tissues and 
animal products. In Argentina DOX is frequently used in poultry 
production; therefore, it is important to control its residues in edible 
tissues. Doxycycline given to chickens orally raise possibility for 
residues which may remain in edible tissues, particularly when 
animals are slaughtered without respecting the withdrawal period. 
There are several factors which may increase the risk of accumulation 
of DOX in poultry tissues such as imprudent use for overdosing, 
misuse, insufficient withdrawal time and failure in the doses. Such 
residues may cause public health hazards to consumers including 
toxicological, microbiological, immunological and pharmacological 
disorders depending on the type of food and the amount of residue 
present.11
Residual levels of DOX in animal tissues have several potential 
risks for consumers. One of them is the potential hazard to select 
resistance in commensal strains of medicated animals. Those selected 
resistant commensal strains become a problem because the plasmids 
containing resistance genes could be transferred to human bacteria.12 
Additionally, bacterial populations do not respond to traditional 
treatments commonly used for human illnesses.13
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Abstract
Doxycycline (DOX), tetracycline of second generation, is mainly active against Gram–
positive and Gram–negative bacteria, aerobic and anaerobic. Although there are few 
pharmacokinetic studies in chickens, it is frequently used for the colibacillosis treatment, 
salmonellosis, staphylococcal infections, avian mycoplasmosis and chlamydia. The 
objective of this study was to evaluate the withdrawal time (WT) of DOX formulation at 25 
% in edible tissues, after its oral (PO) use in broilers. Forty healthy chicks (30–35 days of 
age) were used. DOX was administered with drinking water for 5 days at 10 mg kg–1 (N = 
36); four untreated animals were reserved (control). Six animals per group were euthanized 
by cervical dislocation after desensitization by passage of an electric current through the 
head, after 24 hours until 9 d post treatment and control animals also. Muscle, liver, kidney 
and skin/fat samples were obtained. DOX was determined by HPLC with UV detection. 
DOX concentrations were determined in all tissues examined; generally falling below the 
MRL at 7 d after administration is terminated. It was estimated 6.58, 8.18, 8.69 and 6.96 d 
of WT for muscle, liver, kidney and skin/fat, respectively. After DOX administration at a 
rate of 10 mg kg–1 for 5 days in drinking water, a WT of 9 d is suggested in poultry destined 
for human consumption.
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The antibiotics’ residue levels reached in organs and the rate of 
their depletion from tissues depend on the method of administration, 
animal species, as well as dose and specific formulation of a given 
drug. The differences in the antibiotic concentration and time of its 
depletion may also be influenced by the differences in the intake of 
drinking water by animals as well as its quality. Studies on tissue 
concentrations after different drug formulation administration are 
essential to control antibiotic residues in food animal products, in 
order to recommend the appropriate withdrawal time.
The European Commission has established limits for maximum 
residues (MRLs) allowed in foodborne products from poultry industry, 
in muscle the MRL is 100 μg kg–1; 300 μg kg–1 in liver and skin/fat 
and 600 μg kg–1 in kidney. According to the Commission Regulation14 
and EMA Summary Report Doxycycline 2, quantification of DOX in 
animal tissues requires a determination of only the parent compound 
as the residue marker, without its 4–epimer, contrary to other 
tetracyclines for which the MRLs are defined as a sum of parent drugs 
and their 4–epimers (EU N° 37/2010, EMEA/MRL/270/97, 1997). 
The purpose of the present study was to evaluate the withdrawal time 
(WT) of experimental DOX formulation at 25% in edible tissues, after 
its PO use in broilers.
Materials and methods
Study location
Experimental animals were provided by a farm located in Buenos 
Aires province, Argentina. All the in vivo assays were performed 
at the Laboratory of Pharmacological and Toxicological Studies 
(LEFyT,)–School of Veterinary Science, National University of La 
Plata, Argentina.
Experimental formulation
Doxycycline was formulated as a 25% experimental water soluble 
powder (DOX 25g, Tartaric acid 5g and Lactose sqt 100g).
Study design treatment and administration 
Sixty healthy BB chickens destined for fattening were kept for 30 
days with water and food free of any type of antibiotic.
The determination of individual daily water consumption is 
complicated in chickens and in general results in unreliable data. 
The control of water consumption, therefore, was made with the 
experimental group constituted in its entirety. The animals were fed 
with balanced feed and water “ad libitum”. To know the real amount 
of water consumed daily, a trial was performed five days before the 
initiation of the treatment with cubed drinkers graduated. Consequently, 
water ingested was measured day by day for five consecutive days. In 
this way it could be ensured that the water ingested daily was that 
which would correspond to the dose of the medication that would be 
administered in the assay in order to decrease the risk of under dosing.
The experiment was conducted on 40 five–week–old chickens, 36 
animals were treated with 10mg kg–1 body weight of DOX (25%) once 
a day, during five consecutive days with drinking water. Solution was 
prepared by dilution of 400 g of the medicament in 1000mL water. 
The solution was prepared in a base of a daily use and containing the 
necessary amount of antimicrobial for an exact dosage. After that, the 
next day, the water administration system was completely emptied, 
washed and a new solution was prepared. The same procedure was 
repeated until day five. After the finalization of the antimicrobial 
administration, the system was suitably washed and loaded with water 
free of any chemical compound.
The birds were kept in a special space designed for performing 
experiments on animals and before treatment they were deprived of 
water. Antibiotic free food was available ad libitum.
Chickens treated with DOX were euthanized by cervical dislocation 
after desensitization by passage of an electric current through the head 
1d, 2d, 3d, 5d, 7d and 9d after the last administration (six animals 
at each time point) and then muscle (breast), liver, skin plus fat and 
kidney were collected. Four chickens used as controls were euthanized 
before the experiment, and same tissues samples were collected. All 
samples were kept separately at–20 °C until analysis.
The protocol was according to the Guide for the Care and Use 
of Agricultural Animals in Agricultural Research and Teaching 
(Federation of Animal Science societies –FASS–) and was approved 
by the Experimental Ethics Committee of the Faculty of Veterinary 
Science, UNLP, Argentina.
Reagents 
Doxycycline (DOX) standard was obtained from Sigma–Aldrich 
Chemical Company (USA). Acetonitrile and methanol were from 
J.T. Baker. Oxalic acid dehydrate, trichloroacetic acid and sodium 
sulphate anhydrous were from Fluka (USA). Solid phase extraction 
(SPE) columns (Strata C18, 100mg, 1mL) and analytical column 
(Luna C18) were obtained from Phenomenex (USA). 
Standard solutions 
Stock standard solution (1mg mL–1) was prepared by weighing 
10.0±0.1mg of standard substances and dissolving in 10mL of 
methanol. The stock solution was stored at –20 ºC in amber glass and 
was stable for six months. Secondary standard solutions (100μg mL–1 
and 10μg mL–1) prepared in methanol by diluting suitable aliquot of 
stock standard were stable for one month, stored at 2–8 ºC in amber 
glass. Working standard solutions in mobile phase were prepared on 
the day of analysis.
Extraction and clean–up
A sample of 0.4 g tissue (problem or spiked with DOX) was 
homogenized with 1.4mL of Mc–Ilvaine buffer–EDTA (pH 4), shaken 
at high speed, and centrifuged at 2.500 g at 4 °C for 15 min. The upper 
layer (supernatant S1) was transferred into a new tube. The extraction 
was repeated three times. The supernatants S2, S3 and S4 were 
coupled with S1. The mixture was vortexed for 30 s and centrifuged 
again for 10 min at 2500g at 4 °C. Mc–Ilvaine buffer–EDTA (pH 
4) was prepared by dissolving 15 g of disodium monohydrogen–
orthophosphate dehydrate, 13g of citric acid and 3.72g of EDTA in 
water and diluting to 1L.
Cleanup 
The supernatant mix (S1–S2–S3–S4) was transferred to SPE C18 
cartridges, which were preconditioned with 3mL of methanol and 
2mL of ultrapure water. The tube reservoir mix supernatants were 
washed with 1mL of McIlvaine buffer–EDTA and 1mL of water, after 
percolation of the whole solution; the columns were washed with these 
solutions (under vacuum). After drying for 2 min, the doxycycline 
was eluted with 4mL of methanol 0.01 M oxalic acid pH 2.0. The 
cleaned extracts were evaporated to dryness in nitrogen evaporator 
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at 40 °C. The dried residues were reconstituted in 200 µL mobile 
phase. After vortexing and centrifugation, 100µL were injected into 
the chromatographic system.
LC–UV analysis
The instrumental analysis was performed using Gilson HPLC 
system, equipped with isocratic pump, autosampler, column oven, 
and UV/Vis detector (λ=346 nm), controlled by Unipoint Workstation 
software. Chromatographic analyses were performed on Luna 
(Phenomenex) C18 column (5μm, 150mm x 4.6mm) with mobile 
phase consisting of water–acetonitrile with 0.02 M oxalic acid and 
0.0005M EDTA (72:28, v/v) at 1.2mL min–1 flow rate. The column 
oven temperature was controlled at 30 ºC.
Method validation 
The following parameters were evaluated for the analysis of each 
matrix: linearity (concentrations of DOX ranging between 0. 1 and 
6 µg ml–1 – µg g–1), precision and accuracy, limit of quantization, 
limit of detection and selectivity. The standard calibration curve was 
prepared by the injection of standard solutions on seven levels (0.1, 
0.2, 0.5, 1, 2, 4 and 6 µg mL–1 or µg g–1). The correlation coefficient 
was evaluated.
Tissue samples were spiked with the DOX working solution to 
levels corresponding to 0.2, 0.5, 1 and 2µg g–1. Six spiked samples 
(of each tissue) with DOX were analyzed within three different days. 
Based on these spiked samples replicates, the precision (repeatability 
and reproducibility) of the method was determined. The mean 
accuracy (expressed as % recovery) was evaluated by comparing the 
concentrations in the spiked samples with known amounts of analyses 
to the concentrations in standard solution which should be within 
the range 85–115%, while the variation in precision should be≤20% 
(coefficient of variation–CV–). The limit of detection (LOD) was 
estimated through the analysis of 20 aliquots of control tissue (free 
of DOX). The noise of the base–line was measured; the average and 
the standard deviation were calculated. The LOD corresponds to three 
of those SD (sign/noise≥3/1) and the limit of quantization (LOQ) 
corresponds to ten of these SD (sign/noise≥10/1).
Withdrawal time
Numerous experimental designs and statistical approach are used 
to establish the withdrawal time. The EMA recommends the use of a 
linear regression analysis of the logarithmic transformed data as the 
choice method.15 The withdrawal time is determined as the time when 
the one–sided, 95% upper tolerance limit of the regression line with a 
95% confidence level is below the MRL. Doxycycline concentrations 
in function of time found in muscle, kidney, liver and skin/fat were 
plotted and analyzed with the program WT version 1.4 in order 
to recommend a period of withdrawal time for this experimental 
formulation.
Results
The development and validation were successfully accomplished. 
This method performed accurately and reproducibly over a range of 
0.1 to 6 µg mL–1 or µg g–1 for DOX.
Precision of the system
One standard solution was prepared containing 0.2µg mL–1 
of DOX and the precision of the system was evaluated after the 
placement of twenty (20) injections in the chromatographic system. 
In this manner the efficiency of the column and of the system were 
evaluated. After twenty injections a coefficient of variation (CV) of 
5.17% was determined.
Assay linearity
This assay exhibited a linear dynamic range between 0.1 and 6µg 
mL–1. A linear relationship was obtained across one dynamic range (r 
values ranged from 0.9923 to 0.9997) (Figure 1).
Figure 1 Calibration curve of doxycycline standard.
Specificity
Six different samples from control tissue (free of DOX) and 6 
tissue samples fortified with DOX were analyzed by HPLC and 
the corresponding chromatograms were compared. No matrix 
interferences were observed on the chromatograms of the samples 
with the same retention time as doxycycline. The chromatographic 
analysis time was short and DOX was presented in 4 min as a sharp 
and symmetrical peak with no interfering peaks (Figure 2).
Figure 2 Chromatograms of chicken blank muscle and spiked muscle samples 
with DOX at levels of 0.2; 0.5; 1 and 2µg g-1.
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Limit of detection (LOD)
The LODs were 0.040, 0.024, 0.024 and 0.010 µg.g–1 for DOX in 
kidney, skin/fat, muscle and liver respectively. 
Limit of quantitation (LOQ)
The LOQs were 0.095, 0.074, 0.054 and 0.100 µg.g–1 for kidney, 
skin/fat, muscle and liver respectively. 
Intra–day and inter–day recovery and precision
The method for the analysis of tissue samples was thoroughly 
validated and the results are presented in Table 1. To assess the 
inter–day (over 3 days) assay recovery and precision, 6 sets of tissue 
samples were prepared containing DOX at 0.2, 0.5, 1 and 2µg.g–1. 
The inter–day variation in recovery and precision were assessed. The 
mean recovery should be within the range 85–115 % and the variation 
in precision should be 20%. To determine the intra–day recovery and 
precision, 6 replicates of each 4 concentrations were analyzed along 
with duplicate standard calibration curves prepared from 2 separate 
stock solutions (Table 1). 
Table 1 DOX recovery and precision intra–day and inter–day (3) from chickens simple tissues spiked with doxycycline 
Intra–day Inter–day (over 3 days)
matrix r µg/g Recovery (%), n=6 Precision (%), n=6 Recovery (%) Precision (%)
Muscle 0.9949(0.2–2µg/g)
0. 2 99.88 5.35 99.96 5
0.5 89.71 5.5 91.24 4.62
1 109.65 4.53 107.88 2.34
2 97.76 3.31 96.75 2.49
Liver 0.9923
(0.2–2µg/g)
0.2 96.38 8.6 97.8 4.96
0.5 93.13 3.03 101.59 6.61
1 82.28 0.62 90.74 8.34
2 86.45 7.42 93.96 7.44
Kidney 0.9931
(0.2–2µg/g)
0.2 97.5 3.54 104.05 13.03
0.5 93.96 5.66 94.37 2.72
1 106.5 2.12 98.47 8.39
2 97.75 1.06 98.85 1.04
Skin/Fat 0.9951
(0.2–2µg/g)
0.2 89.09 0 86.36 2.73
0.5 98.91 0.03 98.97 3.03
1 105.46 0.07 99.49 5.78
2 98.36 0.1 96.12 2.55
Doxycycline tissue concentrations
Doxycycline concentrations were determined in all tissues 
examined; generally falling below the MRL at 7 d after administration 
is terminated. The mean DOX tissue concentrations (±SD) obtained 
after the PO administration of doxycycline to chickens in muscle, 
liver, kidney and skin/fat tissues are shown on Figure 3. After 
DOX administration to chickens at the dose of 10mg kg–1 for five 
consecutive days through the drinking water, the highest content was 
found for kidney and liver at one day after treatment was completed. 
The maximum determined concentration in the kidney was 6.5μg 
g–1 and in the liver was 4.79μg g–1. On the other hand, muscle and 
skin/fat values were lower, with maximum concentration of 1.46μg 
g–1 and 1.23μg g–1, respectively. Subsequently a rapid decrease in 
DOX concentration was observed in all tissues. At 7 d after treatment 
was completed, the DOX concentration in muscle was above LOQ 
of the method used in this trial. Linear regression analysis of the 
logarithmic transformed data can be considered for the calculation of 
the withdrawal periods. Using this approach, the withdrawal time is 
determined as the time when the one–sided, 95% upper tolerance limit 
of the regression line with a 95% confidence level is below the MRL.
Figure 3 Mean (±SD) tissue concentrations of doxycycline in chickens 
slaughtered 1, 2, 3, 5, 7 and 9 d after oral administration of DOX 25% (dose of 
10mg kg-1 body weight during 5 days).
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In our study, taking into account the MRLs in broilers and 
considering that the marker residue is the doxycycline, the calculated 
withdrawal time was 6.58, 8.18, 8.69 and 6.96 d for muscle, liver, 
kidney and skin/fat, respectively (Figures 4).
Figure 4 Plot of the withdrawal times calculation for DOX in chicken muscle (A), kidney (B), skin/fat (C) and liver (D) at the time when the one-sided 95% 
upper tolerance limit is below the EU MRL for doxycycline after its oral administration (5 doses of 10mg kg-1 body weight of DOX 25%). [Residue marker: 
doxycycline].
Discussion and conclusion
In this study chickens were treated with 10mg kg–1 body weight 
of DOX (25%) once a day, for five consecutive days with drinking 
water. There are several studies which show data about depletion 
of DOX from poultry tissues after experimental administration, but 
some of them used higher doses and different routes of administration 
compared to our study: Anadón et al.10 published that they treated 
poultries with 20 mg kg–1 body weight of DOX orally, once a day, for 
four consecutive days; El–Gendi et al.,16 used a single dose of DOX 
(20 mg kg–1 body weight) intravenously. On the other hand, Gajda et 
al.,4 treated animals with the same doses of the present study (10 mg 
kg–1 body weight of DOX), the same route of administration (orally), 
once a day, for five consecutive days.
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The data obtained in this assay after DOX administration in 
drinking water demonstrates that, at the beginning after treatment, 
DOX reached high concentrations in all edible tissues. One day after 
administration of the last dose, DOX concentration rapidly decreased 
in all assayed tissues, these results are in concordance with those of 
other researches despite the doses and the administration route of 
DOX.10,16,17 Then, the residues decreased gradually and only trace 
concentrations were observed on day 9.
In this study the highest content of DOX was found in the kidney 
and liver at one day after treatment was completed. Coinciding with 
these results, the highest DOX concentrations were observed in kidney 
and liver by other researchers16–19 but the concentrations reported 
by Gajda et al.,18 were higher than ours possibly because DOX was 
administered by syringe into the crop of each chicken.
Other authors16,17 have reported that doxycycline residues are still 
present in chicken tissues five days after oral administration, and 
the concentrations are dependent on the applied dose. Other factors 
that affect the levels of residues can be the administration route, 
formulation type, excipients and particularly the robustness of the 
analytical methodology used to quantify the concentrations of the 
assayed compound.
As final conclusion, results from the present assay demonstrate 
that DOX oral administration at the dose of 10mg kg–1 for five days 
in drinking water requires 9 days of withdrawal time for human 
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